Amedeo's Top 20

Amedeo Smart

Independent Medical Education


01 August 2022

Multidisciplinary Journal Club

  1. Cortes J, Rugo HS, Cescon DW, Im SA, et al.
    Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
    N Engl J Med 2022;387:217-226.

  1. Cold S, Cold F, Jensen MB, Cronin-Fenton D, et al.
    Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.
    J Natl Cancer Inst 2022.

  2. Tao C, Qureshi AI, Yin Y, Li J, et al.
    Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
    Circulation 2022.

  3. Kim BK, Hong SJ, Lee YJ, Hong SJ, et al.
    Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-infe
    Lancet 2022.

  4. Nakamura K, Hernandez G, Sharma GG, Wada Y, et al.
    A Liquid Biopsy Signature for the Detection of Patients with Early-Onset Colorectal Cancer.
    Gastroenterology 2022.

  1. Fornecker LM, Lazarovici J, Aurer I, Casasnovas RO, et al.
    Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
    J Clin Oncol 2022.

  2. Timmerhuis HC, van Dijk SM, Hollemans RA, Umans DS, et al.
    Perforation and Fistula of the Gastrointestinal Tract in Patients with Necrotizing Pancreatitis: a Nationwide Prospective Cohort.
    Ann Surg 2022.

  3. Elsheikh R, Tien HT, Makram AM, Van NT, et al.
    Acute Hepatitis of Unknown Origin in Children: Behind the Statistics.
    Hepatology 2022.

  4. Smyth D, Britton Z, Murdin L, Arshad Q, et al.
    Vestibular migraine treatment: a comprehensive practical review.
    Brain 2022.

  5. Bessissow T, Kron CM, Marcus V, Lemieux C, et al.
    Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis.
    Am J Gastroenterol 2022.

  1. Ramnarayan P, Richards-Belle A, Drikite L, Saull M, et al.
    Effect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Therapy on Liberation From Respiratory Support in Acutely Ill Children Admitted to Pediatric Critical Care Units: A Randomized Clinical Trial.
    JAMA 2022;328:162-172.

  2. Nagaraj K, Wei DY, Puledda F, Weng HY, et al.
    Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype.
    Headache 2022.

  3. Lyu H, Zhao S, Li J, Li X, et al.
    Denosumab and Risk of Community-acquired Pneumonia: A Population-based Cohort Study.
    J Clin Endocrinol Metab 2022;107:e3366-e3373.

  4. Johansson A, Dar H, van 't Veer LJ, Tobin NP, et al.
    Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.
    J Clin Oncol 2022.

  5. Howard FM, Pearson AT, Nanda R.
    Clinical trials of immunotherapy in triple-negative breast cancer.
    Breast Cancer Res Treat 2022.

  1. Papatheodoridis GV, Lekakis V, Voulgaris T, Lampertico P, et al.
    Hepatitis B Virus Reactivation Associated with New Classes of Immunosuppressants and Immunomodulators: A Systematic Review, Meta-analysis, and Expert Opinion.
    J Hepatol 2022.

  2. Dember LM, Hung A, Mehrotra R, Hsu JY, et al.
    A randomized controlled pilot trial of anakinra for hemodialysis inflammation.
    Kidney Int 2022.

  3. Choi SA, Lee H, Kim K, Park SM, et al.
    Mortality, Disability and Prognostic Factors of Status Epilepticus: A Nationwide Population-Based Retrospective Cohort Study.
    Neurology 2022.

  4. Borland E, Edgar C, Stomrud E, Cullen N, et al.
    Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials.
    Neurology 2022.

  5. Pitiyarachchi O, Friedlander M, Java JJ, Chan JK, et al.
    What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (>/=10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and in
    Gynecol Oncol 2022.


more..


Privacy Policy